Please login to the form below

Wilmington Healthcare wins first client for new NHS transformation tracker

Product helps pharma identify opportunities and tailor solutions to a changing NHS

Healthcare intelligence provider Wilmington Healthcare has won its first client for an innovative new service that helps pharma keep abreast of change within local NHS organisations and better understand their strategic priorities.   The Healthcare Transformation Tracker, which is a Key Account Management (KAM) tool, enables pharma to search lengthy NHS documents at the touch of a button to identify opportunities within specific regions and allocate resources appropriately.  

The product, which is now being used by a top pharma company, helps industry follow NHS change within three critical categories - disease and therapy areas; infrastructure, such as NHS estates, finance and transport, and the NHS transformation agenda.

Searches can be conducted across NHS organisations, such as trusts and Clinical Commissioning Groups (CCGs), within a Sustainability and Transformation Partnership footprint. Documents that can be perused include STP plans, operating plans, commissioning plans and board meeting papers.

For example, by searching on the term ‘diabetes’, a client can find out what individual STPs and their constituent organisations are saying about it; how services are being redesigned for it in different geographical regions and what is happening to enable this change with regards to NHS infrastructure.  

To ensure they are targeting the appropriate personnel within local NHS organisations, pharma can also use the tracker to keep abreast of structural changes. For example, it can find out if a specific group of CCGs has formally merged or is acting as a single entity.  

The service replaces Wilmington Healthcare’s STP tracker, that was launched in 2016, and reflects the radical change that continues in the NHS as ten areas prepare to become Integrated Care Systems (ICSs).

Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Accessing key influencers within the NHS is becoming increasingly difficult for pharma. When companies do secure meetings, they should have a sound grasp of what is happening within a specific locality and go armed with a tailored solution that meets clearly identified needs.

“The transformation tracker helps pharma operate in this strategic and highly targeted way by enabling it to quickly extract relevant snippets of information from lengthy strategic documents and follow changes within the NHS as they unfold in different ways across different parts of the country.”  


Notes to Editors
For more information, please contact:
Andrew Baud and Catherine McNulty, Tala, +44 (0) 20 3397 3383 or +44 (0) 7775 715775, Email: /

About Wilmington Healthcare and Wilmington plc
Wilmington Healthcare within the UK, incorporates HSJ, Binley’s, OnMedica, and Wellards . A part of Wilmington plc whose group companies help clients turn data into actionable business benefit, Wilmington Healthcare focuses on working with its customers to turn its high quality healthcare data into meaningful intelligence to support their business objectives and the improvement of healthcare. For further information, visit

Wilmington plc focuses on three key knowledge areas: Risk & Compliance, Professional, and Healthcare. Wilmington’s businesses enable professionals and their organisations to perform better by providing quality, relevant and reliable information, education and networking. For more information on Wilmington plc visit

24th July 2018


Company Details

Wilmington Healthcare

01268 495600

Contact Website

Beechwood House
2-3 Commercial Way
Christy Close
SS15 6EF
United Kingdom

Latest content on this profile

Covid-19: how is it affecting prescribing patterns?
Oli Hudson, Content Director at Wilmington Healthcare, analyses prescribing data in three key disease areas
Wilmington Healthcare
Wilmington Healthcare launches new platform to map the formulary landscape
Healthcare intelligence provider Wilmington Healthcare has launched a new platform that enables pharma companies to develop a clear picture of formulary status across therapy areas and territories in the UK.
Wilmington Healthcare
Wilmington Healthcare appoints new Head of Digital

Wilmington Healthcare
How has the pandemic reshaped the NHS in 2020?
Oli Hudson, of Wilmington Healthcare, explores the major changes that have occurred across the NHS as key aspects of the Long Term Plan are rolled out at speed.
Wilmington Healthcare
Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset
Wilmington Healthcare
How can pharma align its brand strategy with the NHS Reset?
Oli Hudson, of Wilmington Healthcare, explores how pharma should respond to plans to ‘reboot’ the NHS during the covid recovery era
Wilmington Healthcare